Maravai LifeSciences Corp (MRVI): רווח נקי למניה (EPS TTM)

Effective management at Maravai LifeSciences (MRVI) ensures high returns through the supply of components for mRNA therapies. Net income per share over the last four quarters on GURU.Markets demonstrates inflation adaptation, where the value of -0.45 characterizes this level. Maravai LifeSciences (MRVI) leads in the synthesis of pure nucleic acids through R&D while adhering to strict environmental regulations for laboratory waste disposal.
פילוחי נתונים אנליטיים מרוכזים עבור Maravai (MRVI)

This indicator measures the real equity value of the business by calculating annual net income without the impact of share issuance, allowing for an assessment of true capital generation efficiency. For Maravai LifeSciences (MRVI), the rolling net income per share reflects the monetization of CleanCap patents and integration into pharmaceutical programs, confirming the company's fundamental resilience in the face of market volatility.